World Health Organization Grants Second Emergency Use Listing for Novavax COVID-19 Vaccine

Nuvaxovid™ COVID-19 Vaccine (SARS-CoV-2 rS [Recombinant, adjuvanted]) listed for emergency use by the WHO EUL for Nuvaxovid complements listing for Novavax vaccine manufactured and marketed by Serum Institute of India as Covovax™ EUL...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials